LONDON, Oct. 11,
2024 /PRNewswire/ -- Hugues Péribère, CEO of
Overseed, has been named CEO of the Year in Europe's Biopharmaceutical Industry in
the 2024 Business Worldwide CEO Awards.
Internationally acclaimed for celebrating the most esteemed
C-level executives, the awards recognise outstanding leaders across
a wide range of industries. The focus is on the visionaries—CEOs,
Managing Directors, and senior managers—whose leadership drives
their organisations to success.
Péribère's achievement highlights his exemplary work in leading
Overseed, a pioneering force in France's biopharmaceutical landscape,
particularly in medical cannabis production. Under his
leadership, Overseed has emerged as a frontrunner in the
development of pharmaceutical-grade medical cannabis in
France. With expertise in
genetics, agronomy, and pharmaceutical chemistry, Overseed is set
to become the first French manufacturer of 100% cannabis-based
medicines, helping to shape the future of healthcare as
France prepares for the
legalisation of medical cannabis in 2025.
Péribère, an agronomic engineer with a strong background in
managing specialised plant cultivation across Europe, founded Overseed in 2020. His deep
understanding of supply chains, geopolitical and climatic issues
related to production, and the medical benefits of cannabis has
positioned Overseed as a key player in addressing critical public
health needs through innovative cannabinoid treatments.
The company is dedicated to producing high-quality,
pharmaceutical-grade cannabinoid products that meet the needs of
patients suffering from conditions such as chemotherapy side
effects, multiple sclerosis, and neuropathic pain. By focusing on
national sovereignty and producing its treatments within
France, Overseed ensures reliable
patient access and mitigates risks of supply chain disruptions.
"Overseed is not just about responding to market demands; we
are building an industry that will serve the public health of
France for years to come,"
said Péribère. "This award reflects our team's commitment to
advancing medical research and setting a high standard for
cannabinoid-based therapies."
Overseed has been a leader in research and development since
2021, when it became the first company to receive R&D
authorization for the cultivation of Cannabis sativa L. in
France. The company's partnerships
with institutions such as the CNRS/CBM and the University Hospital
of Orléans have enabled critical research into expanding the
therapeutic use of cannabis.
With plans to further scale its operations, Overseed is set to
meet the growing demand for medical cannabis as legalisation
approaches. Overseed's diverse product portfolio, including CBD-
and THC-dominant oils, will address the specific needs of patients
suffering from conditions approved for medical cannabis
treatment.
To learn more about Overseed's journey and its pioneering work
in medical cannabis production, visit www.overseed.fr.
Further information about the Business Worldwide CEO Awards can
be found at https://www.bwmonline.com/2024-ceo-awards-winners/
About Business Worldwide Magazine
Business Worldwide Magazine is the leading source of business
and dealmaker intelligence throughout the world. Our quarterly
magazine and online news portal enable an established audience of
corporate dealmakers to track the latest news, stories and
developments affecting the international markets, corporate
finance, business strategy and changes in legislation. This
readership includes CEO/CFO - Banks, Corporate Lawyers and Venture
Capital/Private Equity Companies to name a few.
Contact
David Jones
Awards Department
E: david@bwmonline.com
W: www.bwmonline.com
View original
content:https://www.prnewswire.co.uk/news-releases/hugues-peribere-of-overseed-named-in-the-2024-business-worldwide-magazine-ceo-awards-302273464.html